Smartphone-attached stethoscope targets Third World; BD Diagnostics gets clearance for MRSA test;

@FierceMedDev: Luminex snaps up diagnostics firm GenturaDx for $50M in cash. Item | Follow @FierceMedDev

 @MarkHFierce: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @MarkHFierce

 @DamianFierce: Stryker is recalling two all-metal hip implants after reports of corrosion and failure. Story | Follow @DamianFierce

> Australian scientists have designed a cheap-to-manufacture stethoscope that can be attached to a smartphone, hoping to improve access to medical care in the Third World. News

> Becton, Dickinson's diagnostics unit scored 510(k) clearance for a molecular test that identifies methicillin-resistant staphylococcus aureus (MRSA), an infectious disease commonly spread in hospitals. Release

> Ireland's NUI Galway is looking to mimic Stanford's Biodesign fellowship, bringing together academics to take conceptual devices from the lab to the marketplace. Article

> Devicemaker Restoration Robotics got a CE mark for the Artas system, a hair loss-treating device that harvests follicles directly from the scalp in a minimally invasive procedure. More

> Ventus Medical has launched Theravent, a snore-therapy device that received FDA clearance in June. Report

Biotech News

 @FierceBiotech: Australian ‪cancer‬ ‪biotech‬ spin-out Alchemia pitches $60M ‪IPO‬ stateside. More | Follow @FierceBiotech

 @JohnCFierce: Israel's RDD Pharma raised a bit more than $7M from Orbimed to develop drugs delivered up the anal canal. More | Follow @JohnCFierce

 @RyanMFierce: Biotech‬ Genkyotex nails down $26M to fund drug for diabetic kidney disease. More | Follow @RyanMFierce

> Rival sources tangle over claim that Celgene is mulling 'horrid' HGS bid. Article

> Experimental vaccine knocks the weight off flabby mice. More

> Dissidents trigger big shake up at QLT after board coup. News

Pharma News

 @FiercePharma: ‪Merck‬ KGaA says it'll stop investing in R&D in Portugal if drug bills don't get paid. More | Follow @FiercePharma

> Lilly could net $1.5B-plus from Cymbalta extension. Story

> Med students protest as Massachusetts relaxes pharma gift ban. Article

> Is it or isn't it? Celgene said to mull bid for HGS, or not. More

> Forest urges investors to reject Icahn's board nominees. News

Biotech IT News

> Mount Sinai Medical Center, Cloudera embrace Big Data in genomics. Story

> Voice software offers potential tool for clinical trials. Article

> ERT scoops up Invivodata for ePRO clinical trials tech. More

> Mytrus aligns leadership for at-home clinical trials biz. News